A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking
NCT ID: NCT06145763
Last Updated: 2025-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
776 participants
INTERVENTIONAL
2025-07-03
2028-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE Trial
NCT06697496
iCanQuit Smoking Cessation Among Hispanic Adults
NCT06811038
Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
NCT06556238
Smoking Cessation for American Indians
NCT01106456
Connecting Alaska Native People to Quit Smoking
NCT03645941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ARM I: Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors for at least 45 days on study.
ARM II: Participants use the NCI QuitGuide app for at least 45 days on study.
After completion of study intervention, patients are followed up at 3, 6, and 12-months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (iCanQuit app)
Participants use the iCanQuit app, which includes setting up a personalized quit plan, participating in eight levels of the content, receiving on-demand help in coping with smoking urges, and tracking their daily smoking behaviors for at least 45 days on study.
Biospecimen Collection
Ancillary studies
Smoking Cessation Intervention
Use iCanQuit smartphone app
Survey Administration
Ancillary studies
Arm II (NCI QuitGuide app)
Participants use the NCI QuitGuide app for at least 45 days on study.
Biospecimen Collection
Ancillary studies
Smoking Cessation Intervention
Use NCI QuitGuide smartphone app
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biospecimen Collection
Ancillary studies
Smoking Cessation Intervention
Use iCanQuit smartphone app
Smoking Cessation Intervention
Use NCI QuitGuide smartphone app
Survey Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 and older
* Has smoked daily for the past year
* Interest in quitting smoking within the next 30 days
* Willing to be randomly assigned to either app
* Have daily access to their own Android or iPhone
* Able to download a smartphone app
* Be willing and able to read English
* Not currently or within past 30 days using other smoking cessation behavioral interventions or smoking cessation pharmacotherapies
* Have never participated in our prior research
* Have no other household or family member participating
* Being willing to complete the 3, 6, and 12-month follow-up assessments
* Providing email, phone number(s), and mailing address
* Living off United States (US) AIAN tribal reservations or living on five Northern Plains tribal reservations from whom we would obtain approvals to recruit
Exclusion Criteria
* Has participated in our prior research trials
* Has used the National Cancer Institute's (NCI's) QuitGuide app
* Not willing to complete a follow-up survey at 3, 6, and 12 months post-randomization
* Not providing email, phone number(s), and mailing address
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan B. Bricker
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-09049
Identifier Type: REGISTRY
Identifier Source: secondary_id
20279
Identifier Type: OTHER
Identifier Source: secondary_id
RG1123796
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.